Company intelligence / Profile preview

Beijing Biostar Pharmaceuticals Co., Ltd.

Ownership: Private
Development stage: Commercial

Overview

Utidelone injectable was approved in China in March 2021 as the first epothilone-based innovative anticancer drug for metastatic breast cancer. It has demonstrated superior efficacy and safety compared to standard regimens in Phase III trials. The oral capsule formulation of Utidelone has completed US Phase I recruitment with encouraging efficacy/safety data; pivotal studies are ongoing in China and the US. Multiple new indications and next-generation formulations are under clinical or preclinical development

Therapeutic areas: Oncology
Modalities: Small moleculesAntibody-drug conjugates (ADC)Nano-formulations
Industry: Biotech

Drug pipeline

2 assets

BG44

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

Luye Pharma Group – partnership for marketing Utidelone injection in ChinaClinical collaborations with major Chinese academic hospitals and multiple US research institutions including Sarah Cannon Research Institute

Beyond the preview

Go deeper on Beijing Biostar Pharmaceuticals Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Biostar Pharmaceuticals Co., Ltd..

Explore the full profile